An EBV-mediated increase in aromatase activity explains why locations of breakpoints (Multimedia Appendix 5) are relatively independent of estrogen receptor status in breast cancer [68] and resemble locations in lymphoid cells (Figures1, 4 and 9). The gene discussed is CYP19A1; the disease is breast carcinoma.